BRAF and thyroid cancer: We previously revealed that FGD1 was normally maintained, hypomethylated and overexpressed by BRAF (V600E) in thyroid cancer cells and in turn observed that it was hyper-methylated after ShRNA-mediated knockdown of BRAF (V600E) in thyroid cancer cell lines (9).